Long-term interleukin-33 treatment delays disease onset and alleviates astrocytic activation in a transgenic mouse model of amyotrophic lateral sclerosis-Reference-Cited by-同舟云学术

Long-term interleukin-33 treatment delays disease onset and alleviates astrocytic activation in a transgenic mouse model of amyotrophic lateral sclerosis

Published:2019-06 Issue: Volume:6 Page:74-86
ISSN:2451-8301
Container-title:IBRO Reports
language:en
Short-container-title:IBRO Reports

Author:

Korhonen Paula^ORCID,Pollari Eveliina,Kanninen Katja M.,Savchenko Ekaterina,Lehtonen Šárka,Wojciechowski Sara,Pomeshchik Yuriy,Van Den Bosch Ludo,Goldsteins Gundars,Koistinaho Jari,Malm Tarja

Funder

Academy of Finland

Publisher

Elsevier BV

Subject

General Neuroscience

Reference93 articles.

1. A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis;Acevedo-Arozena;Dis. Model. Mech.,2011

2. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells;Ali;Proc. Natl. Acad. Sci. U. S. A.,2007

3. Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome;Alves;Brain Res.,2011

4. Behavioural and anatomical effects of systemically administered leukemia inhibitory factor in the SOD1(G93A G1H) mouse model of familial amyotrophic lateral sclerosis;Azari;Brain Res.,2003

5. Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice;Banerjee;PLoS One,2008

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Active secretion of IL-33 from astrocytes is dependent on TMED10 and promotes central nervous system homeostasis;Brain, Behavior, and Immunity;2024-07

2. ST2 levels and neurodegenerative diseases: is this a significant relation?;Annals of Medicine & Surgery;2024-03-12

3. Immunology of amyotrophic lateral sclerosis – role of the innate and adaptive immunity;Frontiers in Neuroscience;2023-11-30

4. IL-33/ST2 Axis: A Potential Therapeutic Target in Neurodegenerative Diseases;Biomolecules;2023-10-08

5. Cause or consequence? The role of IL-1 family cytokines and receptors in neuroinflammatory and neurodegenerative diseases;Frontiers in Immunology;2023-05-08